These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 35599487)
1. COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences. Baazaoui N; Iqbal K J Alzheimers Dis; 2022; 88(2):399-416. PubMed ID: 35599487 [TBL] [Abstract][Full Text] [Related]
2. Impact of the COVID-19 Pandemic on Chronic Neurological Disorders: Focus on Patients with Dementia. Barbieri MA; Bagnato G; Ioppolo C; Versace AG; Irrera N CNS Neurol Disord Drug Targets; 2022; 21(10):1017-1026. PubMed ID: 35021982 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: systematic review with frequentist and Bayesian meta-analyses. Smadi M; Kaburis M; Schnapper Y; Reina G; Molero P; Molendijk ML Br J Psychiatry; 2023 Aug; 223(2):348-361. PubMed ID: 37183681 [TBL] [Abstract][Full Text] [Related]
4. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease. Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161 [TBL] [Abstract][Full Text] [Related]
5. COVID-19 and neurodegenerative diseases. Fu YW; Xu HS; Liu SJ Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4535-4544. PubMed ID: 35776055 [TBL] [Abstract][Full Text] [Related]
6. New-onset neurodegenerative diseases as long-term sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis. Rahmati M; Yon DK; Lee SW; Soysal P; Koyanagi A; Jacob L; Li Y; Park JM; Kim YW; Shin JI; Smith L J Med Virol; 2023 Jul; 95(7):e28909. PubMed ID: 37394783 [TBL] [Abstract][Full Text] [Related]
7. Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS. Szabo MP; Iba M; Nath A; Masliah E; Kim C Exp Mol Med; 2022 Apr; 54(4):447-454. PubMed ID: 35396576 [TBL] [Abstract][Full Text] [Related]
8. The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline. Pyne JD; Brickman AM Neurodegener Dis; 2021; 21(1-2):1-23. PubMed ID: 34348321 [TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms highlighting the potential role of COVID-19 in the development of neurodegenerative diseases. Rahmani B; Ghashghayi E; Zendehdel M; Baghbanzadeh A; Khodadadi M Physiol Int; 2022 Jun; 109(2):135-162. PubMed ID: 35895572 [TBL] [Abstract][Full Text] [Related]
10. Implication of Covid-19 on Neurological Complications with Specific Emphasis on Alzheimer's and Parkinson's Disease. Sood A; Goyal R; Singh H; Behl T; Arora S; Saini B; Kaur R CNS Neurol Disord Drug Targets; 2022; 21(3):235-245. PubMed ID: 34414876 [TBL] [Abstract][Full Text] [Related]
11. COVID-19 Pandemia: Neuropsychiatric Comorbidity and Consequences. Sinanović O; Muftić M; Sinanović S Psychiatr Danub; 2020; 32(2):236-244. PubMed ID: 32796792 [TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Infection to Premature Neuronal Aging and Neurodegenerative Diseases: Is there any Connection with Hypoxia? Sivagurunathan N; Calivarathan L CNS Neurol Disord Drug Targets; 2024; 23(4):431-448. PubMed ID: 37073650 [TBL] [Abstract][Full Text] [Related]
14. COVID-19 in age-related neurodegenerative diseases: is there a role for vitamin D3 as a possible therapeutic strategy? de Barros Viana M; Rosário BDA; de Fátima Santana de Nazaré M; Estadella D; Ribeiro DA; Socorro de Barros Viana G Rev Neurosci; 2021 Feb; 32(2):235-247. PubMed ID: 33185582 [TBL] [Abstract][Full Text] [Related]
15. Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution. Calderón-Garcidueñas L; Torres-Jardón R; Franco-Lira M; Kulesza R; González-Maciel A; Reynoso-Robles R; Brito-Aguilar R; García-Arreola B; Revueltas-Ficachi P; Barrera-Velázquez JA; García-Alonso G; García-Rojas E; Mukherjee PS; Delgado-Chávez R J Alzheimers Dis; 2020; 78(2):479-503. PubMed ID: 32955466 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 and neurodegenerative diseases: what we know and what we don't. Lingor P; Demleitner AF; Wolff AW; Feneberg E J Neural Transm (Vienna); 2022 Sep; 129(9):1155-1167. PubMed ID: 35434769 [TBL] [Abstract][Full Text] [Related]
17. COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable? Ferini-Strambi L; Salsone M J Neurol; 2021 Feb; 268(2):409-419. PubMed ID: 32696341 [TBL] [Abstract][Full Text] [Related]
18. Investigating neurological symptoms of infectious diseases like COVID-19 leading to a deeper understanding of neurodegenerative disorders such as Parkinson's disease. Zhang J Front Neurol; 2022; 13():968193. PubMed ID: 36570463 [TBL] [Abstract][Full Text] [Related]
19. Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson's Disease: A Narrative Review. Morowitz JM; Pogson KB; Roque DA; Church FC Brain Sci; 2022 Apr; 12(5):. PubMed ID: 35624923 [TBL] [Abstract][Full Text] [Related]
20. Alzheimer's and Parkinson's Diseases Predict Different COVID-19 Outcomes: A UK Biobank Study. Yu Y; Travaglio M; Popovic R; Leal NS; Martins LM Geriatrics (Basel); 2021 Jan; 6(1):. PubMed ID: 33530357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]